931 related articles for article (PubMed ID: 17878391)
1. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
[TBL] [Abstract][Full Text] [Related]
2. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
3. A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.
Alvarez-Fernández C; Escribà-Garcia L; Vidal S; Sierra J; Briones J
J Transl Med; 2016 Jul; 14(1):214. PubMed ID: 27435312
[TBL] [Abstract][Full Text] [Related]
4. Transient stimulation expands superior antitumor T cells for adoptive therapy.
Kagoya Y; Nakatsugawa M; Ochi T; Cen Y; Guo T; Anczurowski M; Saso K; Butler MO; Hirano N
JCI Insight; 2017 Jan; 2(2):e89580. PubMed ID: 28138559
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a cell based artificial antigen-presenting cell for expansion and activation of CD8+ T cells ex vivo.
Gong W; Ji M; Cao Z; Wang L; Qian Y; Hu M; Qian L; Pan X
Cell Mol Immunol; 2008 Feb; 5(1):47-53. PubMed ID: 18318994
[TBL] [Abstract][Full Text] [Related]
7. Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells.
Kim YJ; Brutkiewicz RR; Broxmeyer HE
Blood; 2002 Nov; 100(9):3253-60. PubMed ID: 12384425
[TBL] [Abstract][Full Text] [Related]
8. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.
Bertram EM; Dawicki W; Sedgmen B; Bramson JL; Lynch DH; Watts TH
J Immunol; 2004 Jan; 172(2):981-8. PubMed ID: 14707071
[TBL] [Abstract][Full Text] [Related]
9. Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.
Hernandez-Chacon JA; Li Y; Wu RC; Bernatchez C; Wang Y; Weber JS; Hwu P; Radvanyi LG
J Immunother; 2011 Apr; 34(3):236-50. PubMed ID: 21389874
[TBL] [Abstract][Full Text] [Related]
10. Tumor expression of 4-1BB ligand sustains tumor lytic T cells.
Zhang H; Merchant MS; Chua KS; Khanna C; Helman LJ; Telford B; Ward Y; Summers J; Toretsky J; Thomas EK; June CH; Mackall CL
Cancer Biol Ther; 2003; 2(5):579-86. PubMed ID: 14614331
[TBL] [Abstract][Full Text] [Related]
11. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.
Maus MV; Thomas AK; Leonard DG; Allman D; Addya K; Schlienger K; Riley JL; June CH
Nat Biotechnol; 2002 Feb; 20(2):143-8. PubMed ID: 11821859
[TBL] [Abstract][Full Text] [Related]
13. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
[TBL] [Abstract][Full Text] [Related]
14. Changes in lymphocytes' telomerase activity by 4-1BB costimulation.
Ahmad HT; Mansooreh J; Fereshteh M; Mojtaba H
J Cancer Res Ther; 2014; 10(4):998-1003. PubMed ID: 25579543
[TBL] [Abstract][Full Text] [Related]
15. Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation.
Markiewicz MA; Carayannopoulos LN; Naidenko OV; Matsui K; Burack WR; Wise EL; Fremont DH; Allen PM; Yokoyama WM; Colonna M; Shaw AS
J Immunol; 2005 Sep; 175(5):2825-33. PubMed ID: 16116168
[TBL] [Abstract][Full Text] [Related]
16. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway.
Diehl L; van Mierlo GJ; den Boer AT; van der Voort E; Fransen M; van Bostelen L; Krimpenfort P; Melief CJ; Mittler R; Toes RE; Offringa R
J Immunol; 2002 Apr; 168(8):3755-62. PubMed ID: 11937526
[TBL] [Abstract][Full Text] [Related]
17. Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation.
Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
J Immunol; 2002 Nov; 169(10):5780-6. PubMed ID: 12421958
[TBL] [Abstract][Full Text] [Related]
18. Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.
Rudolf D; Silberzahn T; Walter S; Maurer D; Engelhard J; Wernet D; Bühring HJ; Jung G; Kwon BS; Rammensee HG; Stevanović S
Cancer Immunol Immunother; 2008 Feb; 57(2):175-83. PubMed ID: 17657490
[TBL] [Abstract][Full Text] [Related]
19. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.
Bertram EM; Lau P; Watts TH
J Immunol; 2002 Apr; 168(8):3777-85. PubMed ID: 11937529
[TBL] [Abstract][Full Text] [Related]
20. CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells.
Altvater B; Pscherer S; Landmeier S; Niggemeier V; Juergens H; Vormoor J; Rossig C
Clin Exp Immunol; 2006 Jun; 144(3):447-57. PubMed ID: 16734614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]